PJT Partners heads into its July 28 earnings report with short sellers quietly building positions and options traders turning notably bullish — a setup worth watching given the stock's 12% weekly surge.
The short-side story has shifted meaningfully over the past month. Short interest climbed to 8.7% of free float — up roughly 16% from a month ago and 12% just this week. That still leaves the borrow market far from distressed: availability runs near 246% of current short interest, meaning roughly 2.4 shares remain available to borrow for every one already lent out. Cost to borrow nudged up to 0.54% from mid-week lows but remains negligible. What the data shows is a gradual, deliberate rebuild in bearish positioning — not a panic short or a squeeze setup, but shorts adding with discipline into the rally. The ORTEX short score has climbed from 51 at end of June to 60.7 now, its highest reading in recent weeks, reflecting this steady accumulation across SI, cost-to-borrow movement, and availability tightening from a very loose base.
Options traders are reading the same rally differently. The put/call ratio has collapsed to 0.65 — nearly 1.5 standard deviations below its 20-day mean of 1.17 — a sharp reversal from the defensive positioning that held through most of June, when the PCR was running above 1.50. Calls have overwhelmed puts this week, the most bullish options posture of the past year against that mean. That divergence is the tension: one part of the market is buying calls into the 12% rally; another is quietly rebuilding short positions.
The analyst picture is broadly constructive but capped. UBS raised its target to $162 from $160 this week — keeping a Neutral rating — implying the stock at $168.56 has already moved through the bank's upside case. Keefe, Bruyette & Woods carries an Outperform with a $175 target, the more optimistic anchor on the Street. With the mean consensus target at $170 and the stock trading a shade above that, the Street is not pricing in much further upside from here. The earnings track record adds to the cautious backdrop: the last three prints each produced modest negative reactions, including a 2.4% one-day drop following the April report. Factor scores offer little near-term lift — EPS momentum ranks in the 46th percentile on a 30-day basis and the 36th on 90-day, while the short score rank sits in just the 14th percentile, meaning most comparables are less shorted.
Institutional ownership is reasonably stable. BlackRock added 107,000 shares recently to a 14.3% stake. The more notable signal came from insiders: founder and CEO Paul Taubman sold $5.5 million worth of stock in late April, and CFO Helen Meates followed with a $1.2 million sale on May 1. Neither was catastrophic in scale, but paired with the stock's subsequent rally, those disposals at around $151–$153 now look like well-timed exits ahead of the current price level.
The setup heading into July 28 is one where price action and options sentiment argue bullishness while short interest, insider disposals, and a consensus target below the current price all argue restraint — the July earnings print will be the arbiter.
See the live data behind this article on ORTEX.
Open PJT on ORTEX →ORTEX Market Intelligence content is generated by AI from a snapshot of ORTEX's proprietary data. Content is informational only and does not constitute investment advice.
